OR WAIT null SECS
© 2025 MJH Life Sciences™ , Pharmaceutical Technology - Pharma News and Development Insights. All rights reserved.
FDA wants manufacturers to revise product labeling and packaging and step up adverse-event monitoring to reduce risky product use.